Lersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor with Activity against Drug-Resistant Human Immunodeficiency Virus Type 1

類似資料

• Reduced Maximal Inhibition in Phenotypic Susceptibility Assays Indicates that Viral Strains Resistant to the CCR5 Antagonist Maraviroc Utilize Inhibitor-Bound Receptor for Entry
  著者:: Westby, Mike, 等
  出版事項: (2007)
• Nonnucleoside Reverse Transcriptase Inhibitor Hypersusceptibility and Resistance by Mutation of Residue 181 in HIV-1 Reverse Transcriptase
  著者:: Barnard, John P., 等
  出版事項: (2019)
• Impact of the N348I Mutation in HIV-1 Reverse Transcriptase on Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Non-Subtype B HIV-1
  著者:: McCormick, Adele L., 等
  出版事項: (2011)
• TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1
  著者:: Andries, Koen, 等
  出版事項: (2004)
• Antiviral Activity of MK-4965, a Novel Nonnucleoside Reverse Transcriptase Inhibitor
  著者:: Lai, Ming-Tain, 等
  出版事項: (2009)